JUSTIN SCHMIDT: Open Payments
NPI 1134584014 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 29 payments from 10 companies in 2025. Trend: 2023 $760 · 2024 $463 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 9 | $207 |
| Electromed, Inc. | 5 | $96 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Insmed, Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Viatris Specialty LLC | 2 | $30 |
| Medtronic, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Ohtuvayre, SMARTVEST, NUCALA, Arikayce, DUPIXENT, WINREVAIR, YUPELRI, BREZTRI.
Industry payments across CA — which companies pay providers there.
